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Abstract
Background: Major obstetric haemorrhage is a leading cause of maternal mortality and accounts for one-third of
maternal deaths in of Africa. This study aimed to assess the population-based incidence, causes, management and
outcomes of major obstetric haemorrhage and risk factors associated with poor maternal outcome.
Methods: Women with major obstetric haemorrhage who met the WHO maternal near-miss criteria or died in the
Metro East region, Cape Town, South Africa, were evaluated from November 2014–November 2015. Major obstetric
haemorrhage was defined as haemorrhage in pregnancies of at least 20 weeks’ gestation or occurring up to 42 days
after birth, and leading to hysterectomy, hypovolaemic shock or blood transfusion of ≥5 units of Packed Red Blood
Cells. A logistic regression model was used to analyse associations with poor outcome, defined as major obstetric
haemorrhage leading to massive transfusion of ≥8 units of packed red blood cells, hysterectomy or death.
Results: The incidence of major obstetric haemorrhage was 3/1000 births, and the incidence of massive transfusion
was 4/10.000 births in the Metro East region (32.862 births occurred during the studied time period). Leading
causes of haemorrhage were placental abruption 45/119 (37.8%), complications of caesarean section 29/119 (24.4%)
and uterine atony 13/119 (10.9%). Therapeutic oxytocin was administered in 98/119 (82.4%) women and
hysterectomy performed in 33/119 (27.7%). The median numbers of packed red blood cells and units of Fresh
Frozen Plasma transfused were 6 (interquartile range 4–7) and 3 (interquartile range 2–4), ratio 1.7:1. Caesarean
section was independently associated with poor maternal outcome: adjusted OR 4.01 [95% CI 1.58, 10.14].
Conclusions: Assessment of major obstetric haemorrhage using the Maternal Near Miss approach revealed that
placental abruption and complications of caesarean section were the major causes of major obstetric haemorrhage.
Caesarean section was associated with poor outcome.
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Background
Major obstetric haemorrhage (MOH), mostly occurring
postpartum, is a leading cause of maternal mortality
worldwide and accounts for one-third of maternal
deaths in Africa [1–3]. MOH is associated with severe
maternal morbidity, including severe anaemia, dissemi-
nated intravascular coagulation, shock, multi-organ fail-
ure and hysterectomy, as well as long-term psychological
trauma [4–7]. The disparity of maternal deaths (MD) be-
tween low/middle-income and high-income countries is
evident and reflects, among others, differences in the
quality of obstetric care [2, 5, 8, 9]. Multiple factors con-
tribute to these differences, including timely access to
emergency interventions, availability of trained health-
care staff, financial and infrastructural factors [5, 9, 10].
According to the ‘National Committee on Confidential
Enquiries into Maternal Deaths’, there was a 40% in-
crease in deaths due to MOH from 5 to 7 per 100.000
live births in the Western Cape province from 2011 to
2013 and 2014–2016, corresponding with two triennia
reported by the ‘National Committee on Confidential
Enquiries into Maternal Deaths’. This increase in MOH
in the Western Cape contrasts with the decreasing trend
in MOH-related deaths in the whole of South Africa. It
was considered an important worrying epidemiological
finding meriting closer investigation [11, 12].
Given the Sustainable Development Goals’ aim to re-
duce maternal mortality, it is essential to focus on effect-
ive prevention, early diagnosis and improved clinical
management of MOH in this region [13].
The World Health Organization (WHO) maternal
near-miss (MNM) approach (2011) was developed to as-
sess and improve obstetric care by identifying women
who nearly died, but survived severe complications of
pregnancy [14]. Measuring MNM in addition to MD, fa-
cilitates the investigation of a considerably larger group
of women, identification of factors associated with MOH
and evaluation of health care interventions [14, 15].
This study examined women with MOH who met the
WHO organ dysfunction-based MNM criteria or died.
Aims were to assess the incidence, case fatality rate,
causes, management and outcomes of MOH as well as
to examine factors associated with poor outcome, and
evaluate clinical practice regarding massive blood trans-
fusion in the Metro East region, South Africa. In the
near future, this may contribute to revision of protocols
in the attempt to further reduce severe maternal out-
come by MOH.
Methods
A population-based cohort study was designed to de-
scribe organ dysfunction-based MNM and MD due to
major obstetric haemorrhage (MOH) in the public
health sector in the Metro East region, Cape Town,
Western Cape province, South Africa. From 1 November
2014 to 1 November 2015, women admitted to Tyger-
berg Hospital (TBH) were selected who met the MNM
criteria or died and were suffering from MOH after a
gestational age of 20 weeks. In South Africa and in ac-
cordance with the ‘National Committee on Confidential
Enquiries into Maternal Deaths’, antepartum haemor-
rhage is defined as bleeding after 20 weeks gestation.
Bleeding prior to this gestation is classified as miscar-
riage and early pregnancy loss and not as MOH.
Women who met the MNM criteria at TBH, were in-
cluded. TBH is a public tertiary care facility in Cape Town
as well as serving as the academic hospital of the Faculty
of Medicine and Health Sciences of Stellenbosch Univer-
sity, and the referral hospital for Metro East region. TBH
has a well-equipped blood bank as well surgical and med-
ical intensive care units. Women with pregnancy related
critical care problems are treated in the Obstetric Critical
Care Unit in the Department of Obstetrics.
The referral system in Metro East region is organized
according to a three-tiered referral system with midwife-
led units being level 0 for women with low-risk pregnan-
cies. Depending degree of pregnancy related risk, women
will be referred to district hospitals being level 1 or TBH
which serves as both the second and third line referral
centre.
To investigate whether there might have been missing
inclusions of MNM at level 1 hospitals, a three-months
survey was conducted at these institutions, revealing
only three cases. These three women were not included
in this study, because of difficulties in tracing the files.
Besides women who are referred from the Metro East
region, TBH also receives some of the most complicated
cases from other regions within the wider Western Cape
province. In order to calculate accurate incidence rates,
we only used data from patients referred within the
Metro East region and not from the entire Western
Cape Province.
MNM was defined as a woman who nearly died but
survived a complication that occurred during pregnancy,
childbirth or within 42 days after birth or termination of
pregnancy [14]. MOH was defined as haemorrhage, oc-
curring antepartum, intrapartum or postpartum, and
leading to hysterectomy or blood transfusion ≥5 units of
Packed Red Blood Cells (RBCs) or hypovolemic shock,
all of which are considered as markers of MNM [15]. Es-
timated volume of blood loss was not included in the
definition to avoid the inaccuracies associated with vis-
ual estimation [16]. Poor maternal outcome was defined
as MOH followed by massive blood transfusion (defined
as ≥8 units of RBCs) or hysterectomy or MD [17, 18].
Women with MNM were identified on a daily basis
in the obstetric department by accessing admission
and referral books by one of the investigators (AH).
Heitkamp et al. BMC Pregnancy and Childbirth           (2020) 20:14 Page 2 of 8
All healthcare workers (consultants, registrars, medical
officers, nurses, interns, students) were requested to
inform the investigator when a woman who met the
MNM criteria was admitted. Medical files of these
women were screened by two investigators (LV, AH)
using the WHO organ dysfunction-based MNM cri-
teria [14]. Women who met the definition of MOH
as above were included in the data collection. Data
collection was performed using a form specifically
designed for this study including demographic details,
and events before, during and after birth, up to 42
days postpartum. All the patient data were de-
identified upon data collection and were collected
from patient records at TBH and from the files stored
electronically on the protected TBH OpenText Enter-
prise Content Management system. Incomplete data
were attempted to be completed by searching in the
stored original paper files.
TBH has protocols for postpartum haemorrhage and
severe haemorrhage based on international guidelines,
including recommendations on how to administer blood
products. Interventions such as uterine massage and
urinary catheterization were not assessed because, al-
though these interventions are considered standard pro-
cedures, most were not recorded. Arterial embolization
and cell saving equipment were not available.
Statistical analyses
Data were analysed using SPSS version 23.0 (IBM Corp.
Released 2015). Descriptive data are presented as fre-
quencies, percentages, means with standard deviations
if normally distributed and medians with interquartile
ranges (IQR) for skewed data. Associations of poor out-
come with maternal and obstetric risk indicators were
analysed in a multivariable logistic regression model
using risk factors for MOH from the literature [19].
Cross-tabulations were used to determine whether
there was a significant relationship between the ex-
planatory variable and poor outcome. In the multivari-
able logistic regression model, adjusted odd ratios (OR)
for risk factors related to birth were determined, cor-
rected for antenatal risk factors. A maximum of four
antenatal risk factors were included to ensure that the
dataset contained at least ten women for each variable.
In the multivariable logistic regression, P-values < 0.05
were considered statistically significant.
The four antenatal factors were checked for collinear-
ity. Collinearity was determined to be low if the correl-
ation was between 0 and 0.3.
Results
The number of women who gave birth in the Metro East
region during the one-year study period was 32.862. We
identified 119 women who experienced MOH, of which
one woman died. In these 119 women, 112 singletons
and 7 twins were born. The incidence of MNM with
MOH was 3 per 1000 births, and the incidence of
massive blood transfusion due to MOH was 4 per
10.000 births.
The majority of cases (95/119 (75.6%)) were referred
to TBH from a midwife-led unit or level 1 hospital. The
mean age of included women was 28 ± 6.5 SD (16–43)
years, and the median BMI was 26 kg/m2 (range 23–
31). The median gestational age was 36 weeks (range
32–39), with 61/119 (51.2%) women having preterm
birth (Table 1).
Of all women with MOH, 46/119 (38.7%) had poor
maternal outcome, of whom 25/46 (54.4%) underwent
hysterectomy, 12 received massive blood transfusions,
eight had both and one woman died (Table 2).
MOH occurred antepartum in 12/119 (10.1%), intra-
partum in 47/119 (39.5%) and postpartum in 60/119
women (50.4%).
The leading cause of MOH was placental abruption in
45 women (37.8%), followed by complications related to
caesarean section (CS) (vascular and tissue related, not
placenta related) in 29 (24.4%) (Table 3). Characteristics
and outcomes of women with placental abruption are
Table 1 Characteristics of women with MOH (n = 119)
N (%)
Age at delivery (years)
< 20 11 (9.2)
20–34 88 (73.9)
35–39 10 (8.4)
≥ 40 10 (8.4)
BMI




≥ 35 20 (16.8)




≥ 4 6 (5.0)




Full term (> 37) 52 (43.7)
Missing data 6 (5.0)
aNumber of previous births
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shown in Table 4. The mean age (SD) was 25.7 ± 5.9 SD
years and the median gestational age was 33 (29–36)
weeks. No cocaine use or multiple pregnancies were re-
ported in these 45 women.
The majority of women (26/45 (57.8%)) presented
intrapartum, mostly presenting with disseminated intra-
vascular coagulation or shock, and gave birth some
hours later). Ten women (22.2%) presented antepartum
and 9 (20%) women presented postpartum.
Interventions in the management of MOH are presented
in Table 5. For every woman who had MNM due to MOH,
interventions were identified which were performed to
control MOH according to local protocol. The chrono-
logical order of interventions was not retrievable. Thera-
peutic oxytocin was administered (prophylactic dose
immediate postpartum is routine) most frequently to 98/119
women (82.4%) and was the only intervention in one-
quarter of all women. In addition, 34/119 (28.6%) women
received more than one uterotonic drug, and 64/119 (53.8%)
women received a mechanical or surgical intervention.
The ratio of total units of RBCs to total units of
Fresh Frozen Plasma was 1.7:1 (686 units/394 units),
Table 2 Obstetric outcomes of women with MOH (n = 119)
N (%)
Mode of birth
Spontaneous vaginal birth 56 (47.1)
Instrumental 4 (3.3)
Caesarean section 58 (48.7)
Laparotomy for ectopic pregnancy 1 (0.8)
Maternal outcome
Maternal death 1 (0.8)
Poor outcome MOHa 46 (38.7)
Case fatality rate 1 (0.8)
Neonatal outcome (n = 126)
Live births 61 (48.8)
Stillbirths 58 (46.0)
Neonatal deaths 3 (2.4)
Missing data 4 (3.2)
apoor outcome =massive blood transfusion of ≥8 units of RBCs, hysterectomy
or death




with hypertension 35 (29.4)
without hypertension 10 (8.4)
Retained placenta 11 (9.2)
Placenta previa 5 (4.2)






Uterine Atony 13 (10.9)
Perineal trauma 6






Table 4 Characteristics and outcomes of women with placental








Risk factors from past obstetrics history
Hypertensive disease 12 (26.7)
Caesarean section 8 (17.8)
Placental abruption 3 (6.7)
Stillbirth 4 (8.9)
Neonatal death 3 (6.7)
Pregnancy-associated risk factors
Hypertension










Stillbirths on admission 35 (77.8)
Fresh stillbirths 7 (15.6)
CSb for suspected abruption (baby alive before CS) 5 (11.1)
CS with stillbirth 7 (15.6)
Hysterectomy 1 (2.2)
Uterine rupturec 1 (2.2)
Massive transfusiond 5 (11.1)
aduring current pregnancy
bCS Caesarean section
cfailed induction for stillbirth, presented with acute abdominal pain during
laparotomy uterine rupture was diagnosed, hysterectomy was needed
d≥ 8 RBC transfusion
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the median number of RBC per woman was 6 (range
4–6). The ratio in the massive transfusion group was
1.8:1 (207 units/116 units), with a maximum of 41
blood products in one woman.
There were 109 women included in the multivariable
logistic regression, because missing data in one of the
factors meant some women had to be excluded. CS was
independently associated with poor maternal outcome
(OR 4.01; 95% CI 1.58, 10.14) (Table 6). Checking for
collinearity was done and low correlations between oxy-
tocin and CS (correlation coefficient: − 0,204), induction
of labour and CS (correlation coefficient − 0.136) and
prolonged labour and CS (correlation coefficient 0.249)
were found.
Discussion
The main cause of MOH in our study was placental
abruption. The majority of these women suffered from
hypertensive disease of pregnancy and lost their child.
Other frequent causes of MOH were complications dur-
ing or after CS and uterine atony. It is remarkable that
only CS was associated with poor maternal outcome.
Moreover, uterine rupture was seldom encountered in
the overall MNM group.
The reported incidence of MOH is comparable to
prior published incidence rates in Pretoria, South Africa
in 1998 (3 per 1000 births) and 2001 (2.8 per 1000
births) [22, 23]. Incidence rates in high-income coun-
tries are reported to be 2.3 per 1000 births (Ireland in
2011) [24]. The WHO Multicountry Survey on Mater-
nal and New-born Health reported incidence rates for
postpartum haemorrhage of 2.9, 1.4 and 2.0 per 1000
births for low, medium and high Human Development
Index countries in 2012 [5]. Yet, this survey audited se-
vere maternal outcome (MNM and MD) due to post-
partum haemorrhage only, whereas our study included
Table 5 Summary of interventions in the management of MOH by causea
Atony Retained AIPb Abruption CS compli-cationsc Total
N = 13 N = 11 N = 10 N = 45 N = 29 N = 107 %
Medical interventions
Oxytocind 13 10 7 35 24 98 82.4
Ergometrine 7 1 3 1 9 23 19.3
Misoprostol 5 3 – 3 7 20 16.8
Tranexamic acid 2 1 2 4 8 18 15.1




6 – – 1 1 10 8.4
Surgical interventions
Relook laparotomy 5 – 2 2 24 34 28.6
Hysterectomy 6 2 7 1 14 33 27.7
Removal of retained products 3 10 2 4 3 23 19.3
Tear repair in theatre – 2 – 6 2 16 13.4
B-Lynch suture 5 – 1 3 4 13 10.9
Abdominal packing 2 – – 1 1 4 3.4
Artery ligation – – – 1 2 3 2.5
Uterine rupture repair – – – – – 1 0.8
Uterine inversion reversal – – – – – 1 0.8
Management
Transfusion of blood products 13 10 10 45 29 117 98.3
Massive transfusion 1 1 2 5 9 20 16.8
Admission to ICU 2 – 1 1 6 11 9.2
Missing data 3 2.5
athe following causes are not displayed in this table: laceration, uterine rupture and uterine inversion
Interventions for these women are included in the total numbers
babnormally invasive placenta, including placenta previa
cbleeding related to caesarean section
dtherapeutic dose (> 10 IE oxytocin) [21]
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antepartum and intrapartum haemorrhage as well. The
incidence of postpartum haemorrhage in our study was
1.9 per 1000 births, comparable to the medium to high
Human Development Index countries in the WHO sur-
vey. In general, the comparison of incidence rates of
obstetric haemorrhage remains difficult, because defini-
tions vary widely in the literature. On the other hand,
the case fatality rate of MOH was low (0.9%) and is
consistent with the literature [5, 9].
The finding of placental abruption as the main
cause of MOH in our population cannot easily be
compared with other populations since most studies
report antepartum haemorrhage and postpartum
haemorrhage separately. The fact that uterine atony is
not the most frequent cause for MOH is probably
also because our study combines MOH before, during
and after birth [9, 25]. This underlines the import-
ance of including ante- and intrapartum bleeding in
studies of MOH, rather than limiting their scope to
include postpartum haemorrhage only.
Hypertensive disorders of pregnancy, placental abrup-
tion and preterm labour are pathophysiologically related
with early ischemic placental disease [23, 26].
The fact that stillbirths occurred in 95% of women
with abruption was not unexpected, given that the large
majority presented already in shock or with symptoms
of disseminated intravascular coagulation. Despite know-
ledge that appropriate management is to deliver still-
births vaginally, in daily practice this is not always
possible, due to acute maternal compromise requiring
surgical intervention. In this study, we reported a rela-
tively high number of CS in cases of stillbirth. Indica-
tions were maternal condition too poor for induction of
labour (3/7), ≥2 previous CS, (1/7, relative contra-
indication to induce), failed induction (2/7) or ruptured
uterus (1/7).
The high number of complications during and after
CS can be related to the risk factors of the women in
this population. The high percentage of women with
obesity (26.9% BMI ≥30) and hypertensive disorders
may complicate CS. Secondly, lack of skilled doctors
can be associated with poor maternal outcome after
CS [11, 27, 28]. The majority of women with MNM
had low-risk pregnancies and were referred from level
1 hospitals with a high patient burden, mainly man-
aged by medical officers and only one or two obste-
tricians present. Further audit may give more insight
into the quality of care in this setting.
With regard to interventions in the management of
MOH, low rates of intrauterine balloon tamponade, and
administration of tranexamic acid are notable. This can
be explained by the fact that, in 2014, tranexamic acid
was not yet included in the local guidelines. The Bakri
balloon for intrauterine tamponade is a relatively expen-
sive device and therefore rarely utilised at TBH. An al-
ternative and more affordable device, the Ellavi balloon,
was developed in South Africa, but only introduced in
2016 [29].
Even though our study suggests that the local protocol
for management of MOH was followed, detailed infor-
mation - e.g., timing, availability, and quality of the in-
terventions and training of staff – will have to be studied
in more depth in order to identify opportunities to im-
prove management of MOH.
Because of the increasing trend of MOH in the West-
ern Cape province, recommendations from the National
Committee on Confidential Enquiries into Maternal
Deaths to implement guidelines that prevent MOH,
Table 6 Univariate analysis and multivariable logistic regression of risk factors associated poor outcome (defined as massive blood





Missing data Crude OR [95% CI] Adjusted OR
[95% CI]
N (%) N (%) N (%)
Antenatal
BMI≥ 35 11 (23.9) 9 (12.3) 15 (12.6) 2.09 [0.78, 5.60] –
Age at delivery ≥35 11 (23.9) 8 (11.0) 0 2.55 [0.94, 6.94] –
Previous c. section 19 (41.3) 18 (24.7) 3 (2.5) 2.15 [0.97, 4.78] –
Primigravida 12 (26.1) 21 (46.7) 0 0.87 [0.38, 2.01] –
Relating to birth
Prolonged labour 9 (19.6) 4 (5.5) 8 (6.7) 4.43 [1.27, 15.47] 3.72 [0.96, 14.37]
Induction of labour 11 (23.9) 30 (41.1) 6 (5.0) 0.56 [0.20, 1.05] 0.46 [0.18, 1.15]
Oxytocin foraugmentation 5 (10.9) 21 (46.7) 9 (7.6) 0.33 [0.12, 0.97] 0.32 [0.10, 1.05]
Caesarean sectiona 34 (73.9) 24 (32.9) 0 5.79 [2.55, 13.13]*** 4.01 [1.58, 10.14] **
aincludes caesarean section on stillbirth
** < p 0.01
*** < p 0.001
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develop protocols for management of postpartum haem-
orrhage with tranexamic acid and balloon tamponade
and practicing emergency drills, should be prioritised
[11]. .Antenatal care and appropriate blood pressure
control for hypertensive disease are, however, just as im-
portant to prevent MOH and abruptions.
There is no worldwide consensus on blood transfusion
protocols, due to a lack of strong evidence, which is a re-
sult of discrepancy in definitions, resources and only few
available randomized controlled trials [19, 30]. At TBH,
the local severe haemorrhage protocol recommends that,
if bleeding is not controlled after the administration of 4
units of RBCs, to infuse blood products in a ratio of 1
RBC: 1 Fresh Frozen Plasma: 1 platelets. However, our
data does not reflect this recommendation meaning
more individualized care was performed in practice.
We importantly adhered strictly to the criterion of ≥5
RBCs for inclusion as MNM. Nonetheless, we also separ-
ately assessed massive blood transfusion since this assess-
ment enabled comparisons with studies done in other
countries. The incidence of massive transfusion was 40
per 100.000 births and is within the range of the incidence
reported for the United Kingdom between 2012 and 2013
(23 per 100.000 births) and the Netherlands between 2011
and 2012 (65 per 100.000 births) [17, 18], using the same
definition for massive blood transfusion.
The strength of this study is that nearly all women
with MOH from the Metro East region were included in
our database as a result of a well-organized referral sys-
tem. Under reportage was investigated and, in 3 months,
only three women with MNM were missed in the level 1
hospitals, meaning 12 were missed in 1 year so that only
3% of cases of MNM were underreported,. Hence, these
data are considered population-based at district level.
This emphasizes the need and value of a national mater-
nal health care and perinatal data registry, which is not
presently available in South Africa. Limitations of the
study are that, despite our efforts of daily assessment, ei-
ther incomplete documentation or inadequate data ex-
traction from handwritten medical files could have led
to information bias or non-differential misclassification.
For instance, the history of hypertensive disease in preg-
nancy or previous pregnancies was difficult to trace and
the already high prevalence of hypertensive disease of
pregnancy during placental abruption can thus still be
an underestimation. Although the cause of haemorrhage
is likely to be multifactorial, it often involves uterine
atony. Since we only documented the primary cause of
haemorrhage, there might be an underestimation of the
incidence of uterine atony as well.
Conclusions
Our assessment of MOH-related severe maternal out-
come (MNM and MD) shows high rates of morbidity
and low rates of mortality, consistent with the literature.
The incidence of severe maternal outcome due to MOH
is comparable to middle and high-income countries. The
leading cause of MOH was placental abruption suggest-
ing a shift towards ante- and intrapartum haemorrhage.
This, in the WHO terminology (ICD-MM), illustrates
the importance of tracing back the chain of events to
antepartum, rather than focusing on postpartum haem-
orrhage only, which is what often happens in practice.
Hypertensive disorders of pregnancy were present in a
majority of women with placental abruptions, underlin-
ing the association between ischemic placental disease,
hypertensive disorders and haemorrhage. Since caesar-
ean section was independently associated with poor ma-
ternal outcome, careful consideration and vigilance are
needed when deciding on this mode of birth. A focus on
developing an evidence-based massive transfusion proto-
col is important to improve patient safety. Progress re-
mains to be made regarding the reduction of morbidity
rates; hence obstetric audit should be encouraged to
identify opportunities to improve MOH management in
order to avoid hysterectomy, massive transfusion and
placental abruption in women with preeclampsia.
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